28 December 2023>: Articles
IgA Vasculitis as a Potential Complication of Fourth-Line Chemotherapy with Tegafur/ Gimeracil/Oteracil (S-1) in Advanced Non-Small Cell Lung Cancer: A Case Report
Rare coexistence of disease or pathology
Ryotaro Yoneoka A , Hajime Kasai A* , Aoi Hino A , Ayumi Hayashi B , Atsushi Sasaki B , Masayuki Ota B , Katsuhiko Asanuma D , Takuji Suzuki DDOI: 10.12659/AJCR.941826
Am J Case Rep 2023; 24:e941826
Figure 1. (A) Chest radiograph obtained at the first visit to our department revealed a mass extending into the left upper and middle lung field. (B) Upon administration of tegafur/gimeracil/oteracil (S-1) as fourth-line chemotherapy, the mass appeared reduced in size on the chest radiograph, compared with its appearance before chemotherapy. (C) At the time of the appearance of purpura, the tumor was once again enlarged despite treatment with 7 courses of S-1.